Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1YT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,017
Award facts
- Contract value 100% obligated
- $17,017.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,017.21 delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL syringes on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, which serves as the company's corporate office and primary distribution hub for federal pharmaceutical procurement.
This delivery order is issued under AmerisourceBergen's comprehensive Pharmaceutical Prime Vendor Global Program contract vehicle, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems worldwide. Dupixent, a biologic immunosuppressant commonly used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, represents one component of the extensive therapeutic portfolio the company delivers through its DLA Medical Supply Chain agreements. As the prime vendor for this contract, AmerisourceBergen leverages its established federal relationships with the Defense Health Agency and other government healthcare systems to fulfill critical pharmaceutical requirements for military personnel and related beneficiaries.
Quick answers
Who was awarded contract SPE2DR26FG1YT?
SPE2DR26FG1YT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FG1YT worth?
The government has obligated $17,017 on SPE2DR26FG1YT.
Is contract SPE2DR26FG1YT an order under another contract?
Yes. SPE2DR26FG1YT is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1YT competed?
The extent of competition for SPE2DR26FG1YT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award